Evidence map›Paper›PMID 42064643›Full record

ArticleFrontiers in neuroinformatics2026

BrainInsights: a comprehensive framework for pre-processing, analysis, and interpretation of neuroimaging data using traditional statistics and machine learning.

Mageshwar Selvakumar, Andrea Mendez Torrijos, Laura Cristina Konerth, Stefanie Horndasch, Raja Atreya, Arnd Doerfler, Georg Schett, Juergen Rech, Andreas Hess

Abstract read
In one paragraph

Article in Frontiers in neuroinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mageshwar SelvakumarInstitute of Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Andrea Mendez TorrijosInstitute of Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Laura Cristina KonerthInstitute of Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Stefanie HorndaschDepartment of Child and Adolescent Psychiatry and Psychotherapy, Medical School and University Medical Center OWL, Protestant Hospital of the Bethel Foundation, Bielefeld University, Bielefeld, Germany.
Raja AtreyaDepartment of Internal Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Arnd DoerflerDepartment of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Georg SchettDepartment of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Juergen RechDepartment of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Andreas HessInstitute of Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroimaging presents us with an in-depth understanding about brain structure and function, yet the data complexity poses significant analytical challenges. Current frameworks suffer from issues such as scalability, poor integration with traditional statistics and a need for a programing background, which hinder researchers from focusing on neuroscience questions. To address these limitations, we present BrainInsights, an integrated and automated GUI-based pipeline ecosystem designed to facilitate the analysis of multi-modal or multi-parametric neuroimaging data in a flexible way. The framework comprises three core tools: MARIA (MAgnetic Resonance Imaging data Analysis and inspection tool) for data inspection and hypotheses testing, ML Pipeline for automated feature selection and model construction, and ML DaViz for model evaluation and bio-signature generation. Deployed as a singularity container, the system ensures reproducibility and scalability across computing environments. We validated BrainInsights using diverse datasets, including multi-parametric MRI studies of Anorexia Nervosa, Crohn's disease, and Rheumatoid Arthritis. Specifically, the framework distinguished young Anorexia Nervosa patients from controls with a balanced accuracy of 65%, while in the PreCePRA trial, it predicted Rheumatoid Arthritis treatment response with a balanced accuracy of up to 95.4% using functional pain markers. The results demonstrate the ability of the framework to achieve high separation of subgroups and treatment success and additionally bridge hypotheses-driven statistical analysis with data-driven machine learning analysis. By enabling interpretability tools like SHAP, BrainInsights empowers researchers to move beyond "black-box" modeling to uncover stable, biologically plausible bio-signatures. Ultimately, this framework aids in accelerating the translation of complex neuroimaging data into meaningful clinical insights.

Indexed as

clinical translationinterpretable modelsmachine learning frameworkmulti-modal neuroimagingreproducibilitystatistical analysis

Identifiers

PMID42064643
PMCPMC13126547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.